Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Alkermes' combination therapy for cocaine addiction to advance to phase II

Oct. 26, 2010

Omeros receives additional grant from NIDA for addiction program

Oct. 18, 2010

FDA approves Vivitrol for prevention of relapse to opioid dependence

Oct. 13, 2010

Embera NeuroTherapeutics obtains NIDA grant for EMB-001 development

Oct. 5, 2010

Cleveland BioLabs reports on second safety study of CBLB-502

Oct. 1, 2010

FDA approves phase Ib ibudilast trial in methamphetamine-dependent subjects

Sep. 29, 2010

FDA committee recommends approval of Vivitrol for opioid dependence

Sep. 20, 2010

Nabi enters agreement with Diosynth for manufacture of NicVAX nicotine vaccine

Sep. 7, 2010

Cellerant awarded BARDA contract to develop ARS treatment

Sep. 2, 2010

ImmuneRegen to submit proposal for funding Homspera development

Sep. 1, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...